Skip to content

Navigating ‘k-land’: a qualitative exploration of participants’ experiences of ketamine-assisted psychotherapy for methamphetamine use disorder

Kathryn Fletcher, Nadine Ezard, Krista J. Siefried, Sophie van der Helder, Jack Freestone, Jonathan Brett, Robert May, Liam Acheson, Brendan Clifford

Frontiers in Psychiatry June 24, 2026 DOI: 10.3389/fpsyt.2026.1873497 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Qualitative study embedded within an open-label pilot trial Pilot study Peer reviewed
Sample size 14
Population Participants with methamphetamine use disorder who completed core components of ketamine-assisted psychotherapy
Intervention Ketamine-assisted psychotherapy
Topics Esketamine Ketamine Psychedelic-assisted therapy
Keywords Thematic analysis Context archaeology Cognition Qualitative research Intervention counseling Perception Openness to experience Psychological intervention Cognitive behavioral therapy Psychotherapist Clinical psychology Relaxation psychology
Key findings Ketamine-assisted psychotherapy for methamphetamine use disorder was experienced as a context-dependent process in which ketamine facilitated a temporary state of 'psychological space' that supported engagement with psychotherapy, while sustained behavioral change depended on ongoing therapeutic and contextual factors.

Abstract

Background: Methamphetamine use disorder (MAUD) is associated with substantial psychiatric and physical morbidity, and current treatment options remain limited. Ketamine-assisted psychotherapy (KAP) has shown promise in substance use disorders, but little is known about how individuals experience and interpret this intervention, particularly in MAUD. Qualitative investigation may provide insight into perceived mechanisms, acceptability, and factors influencing engagement. This study aimed to explore how participants experienced, interpreted, and evaluated KAP for MAUD.

Methods: This qualitative study was embedded within an open-label pilot trial of KAP for MAUD. Fourteen participants who completed core components of the intervention undertook semi-structured interviews following treatment. Interviews explored motivations for participation, experiences of ketamine dosing and psychotherapy, and perceptions of change. Data were analysed using reflexive thematic analysis.

Results: Four interrelated themes were generated: (1) treatment entry, characterised by prior treatment experience with limited sustained benefit and pragmatic openness to a novel approach; (2) a structured and supportive context for engagement, highlighting the importance of relational safety and clinical containment; (3) altered states and psychological shifts, in which participants described reduced emotional and cognitive reactivity following ketamine sessions; and (4) translation of psychological shifts into behavioural change, describing variable and contingent changes in methamphetamine use. Participants described ketamine as creating a temporary state characterised by reduced emotional and cognitive reactivity and enhanced receptivity, which we interpret as ‘psychological space’. This state appeared to support engagement with psychotherapy, although behavioural change was variable and contingent on ongoing therapeutic engagement, personal motivation, and contextual factors. Acceptability was generally high within a supportive clinical environment. Participants expressed uncertainty regarding whether changes were attributable to ketamine, psychotherapy, or contextual factors.

Conclusions: KAP for MAUD was experienced as a multi-stage, context-dependent process rather than a stand-alone pharmacological treatment. Ketamine was characterised as facilitating a temporary state of ‘psychological space’ that appeared to support engagement with psychotherapy, while sustained change appeared to depend on the integration of these experiences into ongoing cognitive and behavioural processes. These findings support a model in which pharmacological, psychotherapeutic and contextual factors interact, and highlight the need for further research to clarify mechanisms and optimise intervention design.

In the evidence

This study is part of the evidence base for a synthesis in the library. Here is how each one recorded it.

  • Participants experienced ketamine-assisted psychotherapy as a context-dependent process in which ketamine created temporary psychological space supporting psychotherapy engagement, while sustained behavioral change depended on ongoing therapeutic and contextual factors.

    Synthesized

Comparable studies

Other non-randomized and open-label trials on ketamine and psychedelic-assisted therapy, most cited first.

Study Year Design Participants
Ketamine Psychedelic Therapy (KPT): A Review of the Results of Ten Years of Research Alcoholic patients 1997 Controlled clinical trial n = 211
Ketamine-assisted psychotherapy provides lasting and effective results in the treatment of depression, anxiety and post traumatic stress disorder at 3 and 6 months: Findings from a large single-arm retrospective effectiveness trial Adults with a history of depression, anxiety, or PTSD who had not responded to prior... 2023 Retrospective single-arm effectiveness trial n = 1,806
Protocol of an open-label safety and feasibility pilot study of ketamine-assisted psychotherapy for methamphetamine use disorder (the KAPPA trial). Adults meeting DSM-5-TR criteria for methamphetamine use disorder seeking to reduce or... 2025 Open-label, single-arm clinical trial n = 20
Exploratory non-randomized clinical trial of subcutaneous esketamine in treatment-resistant depression: Effects of ketamine-assisted psychotherapy Patients with treatment-resistant depression 2026 Nonrandomized, open-label clinical trial n = 46
Ketamine-Assisted Psychotherapy for Treatment- Resistant Depression with Comorbid Post-Traumatic Stress Disorder in Veterans Ukrainian veterans with treatment-resistant depression and PTSD symptoms 2025 Open-label naturalistic study n = 27

Explore topics

By condition and practice